0000899243-23-011197.txt : 20230412 0000899243-23-011197.hdr.sgml : 20230412 20230412164845 ACCESSION NUMBER: 0000899243-23-011197 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230411 FILED AS OF DATE: 20230412 DATE AS OF CHANGE: 20230412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Allen Robert D. III CENTRAL INDEX KEY: 0001972424 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40703 FILM NUMBER: 23816191 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 178 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invivyd, Inc. CENTRAL INDEX KEY: 0001832038 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851403134 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 178 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 819-0080 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 178 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Adagio Therapeutics, Inc. DATE OF NAME CHANGE: 20201112 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-11 0 0001832038 Invivyd, Inc. IVVD 0001972424 Allen Robert D. III C/O INVIVYD, INC. 1601 TRAPELO ROAD, SUITE 178 WALTHAM MA 02451 0 1 0 0 Chief Scientific Officer 0 Stock Option (Right to Buy) 1.205 2023-04-11 4 A 0 600000 0.00 A 2033-04-10 Common Stock 600000 600000 D This option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date of April 11, 2023 and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date. /s/ Jill Andersen attorney-in-fact for Robert D. Allen III 2023-04-12